Doing some research...
Statement
Assets, liabilities and equity aligned across the annual filing history, in USD millions.
Assets
+4.1% YoYReported for FY 2025
Liabilities
+1.9% YoYReported for FY 2025
Equity
+9.1% YoYReported for FY 2025
Equity mix
+1.5 ppEquity share of the capital base
Table view
Balance sheet, reported dollar amounts — FY 2025
Every figure is the balance as filed. Each filing badge opens the SEC index page for that fiscal year.
Structure
Assets plotted against the liabilities and equity stack, so you can see how the balance sheet is financed.
Liabilities and equity stack to the capital base; assets are the dashed reference line.
Composition
The same split read as a share of total capital rather than in absolute dollars.
Percentages are measured against total capital for each fiscal year.
Trend
How assets, liabilities and equity have moved across the annual balance sheet window.
Switching between bar and line keeps the selected year order.
Commentary
This explanation uses an earlier data snapshot or evidence version. Compare its generation date with the current filing figures.
Earlier AI snapshot · Generated May 31, 2026. The filing-backed figures above are the current source of truth.
Northrop Grumman’s balance sheet has expanded steadily over the five-year period, with total assets rising from **$42.6 billion in 2021 to $51.4 billion in 2025**. The increase was fairly consistent year over year, suggesting continued investment in working capital, program execution, and long-cycle defense contract activity. In a defense/aerospace context, this kind of gradual asset growth is typical for a large prime contractor supporting sizable backlog, government receivables, and capital needs tied to production and development programs. Liabilities also increased over the period, from **$29.7 billion in 2021 to $34.7 billion in 2025**, though the path was a bit more uneven. They declined in 2022 before climbing more sharply in 2023–2025, which could reflect shifting contract liabilities, accrued expenses, or financing-related items. Stockholders’ equity generally strengthened from **$12.9 billion in 2021 to $16.7 billion in 2025**, despite a dip in 2022 versus 2021. Overall, the company appears to have improved its net asset base over time, with equity growth outpacing liabilities in most years, indicating a modestly stronger balance-sheet position and continued financial resilience for a capital-intensive defense business.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.